LexDanaLexDanabeta
Inventor

Nisma MUJAHID

Inventor
US

Overview

4→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07DHeterocyclic compounds20%
PatentTitleYear
12,398,145Bicyclic urea kinase inhibitors and uses thereof202511,878,019Uses of pyrimidopyrimidinones as SIK inhibitors202411,725,011Bicyclic urea kinase inhibitors and uses thereof202311,285,158Uses of pyrimidopyrimidinones as SIK inhibitors2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to DANA FARBER CANCER INST INC (4)· patent assignee history
2022–2025Patents assigned to MASSACHUSETTS GEN HOSPITAL (4)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to BROAD INST INC (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DANA FARBER CANCER INST INC42022–2025
MASSACHUSETTS GEN HOSPITAL42022–2025
BROAD INST INC22023–2025
Locations
LocationPatentsSpan
US42022–2025